High expression level of RCC2 is reported in lung and ovarian cancers, where it functions as a GEF for Rac1, which is subsequently involved in superoxide-induced cell death (Williamson et al., 2014; Wu et al., 2018). The gene discussed is RCC2; the disease is ovarian cancer.